Michael Vi / Shutterstock.com
27 July 2023BiotechnologyMuireann Bolger
Teleflex inks $650m deal with Nordic pharma firm
Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Medtech
8 June 2023 Medtronic’s claims of “obviousness” over cardiologist’s device rejected | US Federal Circuit upholds Teleflex’s catheter technology patents.
Medtech
25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.
Editor's picks
Editor's picks
Medtech
8 June 2023 Medtronic’s claims of “obviousness” over cardiologist’s device rejected | US Federal Circuit upholds Teleflex’s catheter technology patents.
Medtech
25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.
Medtech
8 June 2023 Medtronic’s claims of “obviousness” over cardiologist’s device rejected | US Federal Circuit upholds Teleflex’s catheter technology patents.
Medtech
25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.